Literature DB >> 25257622

Validation and evaluation of VapA-specific IgG and IgG subclass enzyme-linked immunosorbent assays (ELISAs) to identify foals with Rhodococcus equi pneumonia.

M G Sanz1, A F Oliveira1, A Loynachan2, A Page1, V Svansson3, S Giguère4, D W Horohov1.   

Abstract

REASONS FOR PERFORMING STUDY: Rhodococcus equi (Rhodococcus hoagii/Prescottella equi) is a common cause of foal pneumonia, but its diagnosis remains a challenge for equine veterinarians. While the VapA-specific (virulence-associated protein A) immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISA) has low sensitivity and specificity for detecting pneumonic foals, little is known about VapA-specific IgG subclasses.
OBJECTIVES: To evaluate the performance of VapA-specific ELISA for IgG and its subclasses IgGa, IgGb and IgG(T) in the early diagnosis of pneumonia caused by R. equi. STUDY
DESIGN: Assay validation followed by assessment of diagnostic performance using archived samples from animals of known status.
METHODS: Serum samples from exposed (n = 125) and nonexposed adult horses (n = 10) and from experimentally challenged and naturally infected foals were used for ELISA validation. Post mortem and tissue culture records of the last 24 years from the Institute for Experimental Pathology at the University of Iceland in Keldur, Iceland laboratory were evaluated to confirm the absence of R. equi cases in Iceland. The diagnostic performance of VapA-specific IgG and its subclasses was evaluated using banked serum samples from pneumonic (n = 21) and healthy foals (n = 80). To evaluate each IgG assay, a cut-off value was selected based on receiver operating characteristic curve analysis and used to calculate sensitivity and specificity. The intra- and interassay coefficients of variation were calculated for each ELISA.
RESULTS: Using sera from Iceland, where R. equi infection has not been reported, the VapA-specific IgG ELISA differentiated exposed from nonexposed horses. When used to identify infected foals, VapA-specific IgG, IgGa and IgGb had no diagnostic value. In contrast, IgG(T) had high sensitivity and specificity.
CONCLUSIONS: Horses from Iceland are not exposed to VapA(+) R. equi and can serve as negative controls. VapA-specific IgG subclasses, with the exception of IgG(T), are poor predictors of disease. Further investigation on the use of IgG(T) as a diagnostic tool in field conditions is needed.
© 2015 EVJ Ltd.

Entities:  

Keywords:  Prescottella equi; Rhodococcus equi; Rhodococcus hoagii; antibody; enzyme-linked immunosorbent assay; foal; immunoglobulin G subclasses

Mesh:

Substances:

Year:  2015        PMID: 25257622     DOI: 10.1111/evj.12363

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  4 in total

1.  PNAG-specific equine IgG1 mediates significantly greater opsonization and killing of Prescottella equi (formerly Rhodococcus equi) than does IgG4/7.

Authors:  Joana N Rocha; Lawrence J Dangott; Waithaka Mwangi; Robert C Alaniz; Angela I Bordin; Colette Cywes-Bentley; Sara D Lawhon; Suresh D Pillai; Jocelyne M Bray; Gerald B Pier; Noah D Cohen
Journal:  Vaccine       Date:  2019-01-26       Impact factor: 3.641

2.  Seroprevalence of <i>Rhodococcus equi</i> in horses in Israel.

Authors:  Sharon Tirosh-Levy; Sevil E Gürbilek; Osman Y Tel; Oktay Keskin; Amir Steinman
Journal:  J S Afr Vet Assoc       Date:  2017-06-26       Impact factor: 1.474

3.  Oral Administration of Electron-Beam Inactivated Rhodococcus equi Failed to Protect Foals against Intrabronchial Infection with Live, Virulent R. equi.

Authors:  Joana N Rocha; Noah D Cohen; Angela I Bordin; Courtney N Brake; Steeve Giguère; Michelle C Coleman; Robert C Alaniz; Sara D Lawhon; Waithaka Mwangi; Suresh D Pillai
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

4.  Genomic Dissection of an Icelandic Epidemic of Respiratory Disease in Horses and Associated Zoonotic Cases.

Authors:  Sigríður Björnsdóttir; Simon R Harris; Vilhjálmur Svansson; Eggert Gunnarsson; Ólöf G Sigurðardóttir; Kristina Gammeljord; Karen F Steward; J Richard Newton; Carl Robinson; Amelia R L Charbonneau; Julian Parkhill; Matthew T G Holden; Andrew S Waller
Journal:  mBio       Date:  2017-08-01       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.